共 50 条
- [48] Do we have enough evidence for recommending therapeutic apheresis for natalizumab-related progressive multifocal leukoencephalopathy patients? Comment on "Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for apheresis: The seventh special issue." JOURNAL OF CLINICAL APHERESIS, 2018, 33 (03) : 450 - 451
- [50] Critical factors influencing physicians’ intention to use computerized clinical practice guidelines: an integrative model of activity theory and the technology acceptance model BMC Medical Informatics and Decision Making, 16